Hospital Universitario De Canarias — Clinical Trial Site

86 Registered trials

30 Currently recruiting

Organisation

Hospital Universitario De Canarias

Location

San Cristobal De La Laguna, Spain

Identifier

ORG-100048773

Address

Carretera Ofra S/N, 38320, Spain

Departments

#2242; Reumatología
#3403 - Reumatología
3403: Reumatología
Alergología
Alergology
Allergology
Allergy
Cardiology
Endocrinology
Gastroenterology
Gynecology and Obstetrics
Hematología
Hematology
Hematology and Hemotherapy
infectious diseases
Infectious diseases service
Infectious Diseases Unit
Medical Oncology
Medicina Interna
N/A
Nephrology
Neurología
Oftalmologia
Oncologia
Oncologia Medica
Oncology
Oncology Department
Oncology Service
Pediatric
Pediatric Oncology
Pediatric Oncology and Haematology Unit
Reumatología
Rheumatology
Rheumatology Department
Servicio de Endocrinologia
Servicio de enfermedades Infecciosas
Servicio de Hematología
Servicio de Oncologia
Servicio de Oncología Médica
Servicio de Reumatología
Urology

Clinical trials at this site (86)

Search interface

Response-adaptive to Epcoritamab In FIrst Relapse: A Phase II, response-adaptive, Open-Label, Multicenter Study to Evaluate the Efficacy of … Recruiting

2024-514440-86-00 Relapse/Refractory Large B Cell Lymphoma 4 2025-08-04
A Phase 3 Study to Evaluate the Efficacy and Safety of Zasocitinib (TAK-279) in Subjects with Active Psoriatic Arthritis Stratified by Prior… Recruiting

2024-513112-99-00 Active Psoriatic Arthritis Stratified by Prior Biologic 5 2025-06-13
Cetuximab With or Without Paclitaxel After Pembrolizumab-Chemotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck. Recruiting

2024-514953-31-00 Recurrent/Metastatic Squamous Cell Carcinoma of the Hea 4 2025-05-20
A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2024-517513-32-00 Sjögren’s Syndrome 5 2025-05-16
Oral antimicrobial treatment vs. outpatient parenteral for infective endocarditis Recruiting

2024-519969-21-00 Infective endocarditis 6 2025-01-01
A Phase 3, randomized, open-label, multicenter, controlled study to evaluate the efficacy and safety of zanidatamab in combination with phys… Recruiting

2023-508960-31-00 Metastatic HER2-positive breast cancer 5 2024-12-03
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician’s Choice in Patients With Triple Negative Breast Cancer … Recruiting

2024-512279-10-00 Triple Negative Breast Cancer 5 2024-11-25
Ampicillin and ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Recruiting

2024-511719-40-00 Enterococcus faecalis infectious endocarditis 6 2024-10-09
Clinical trial of trabectedin and low-dose radiation therapy in advanced/metastatic sarcomas Recruiting

2023-509215-81-00 Adult and young adult patients with diagnosis of advanc 4 2024-05-22
Phase 3 extension study to evaluate long-term safety of two regimens of ianalumab in participants with systemic lupus erythematosus (SIRIUS-… Recruiting

2023-505929-14-00 Systemic Lupus Erythematosus 5 2024-05-21
STUDY OF OP-1250 ADMINSTERED AS MONOTHERAPY AND COMPARED TO STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2– ADVANCED OR METASTATIC BREAST C… Recruiting

2023-505871-63-00 ER+, HER2- metastatic breast cancer following endocrine 5 2024-04-08
Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults with Active Sjögren’s Syndrome Recruiting

2023-503327-26-00 Sjogren's syndrome 5 2024-01-31
Aspirin versus placebo in twin pregnancies for preeclampsia prevention: A multicentre, randomised, double-blind, placebo-controlled trial (A… Recruiting

2023-503698-40-00 Preeclampsia 5 2023-03-23
A study of tucatinib with trastuzumab and mFOLFOX6 versus standard of care treatment in first-line HER2+ metastatic colorectal cancer Recruiting

2024-514180-25-00 unresectable or metastatic HER2+ colorectal cancer 5 2022-11-21
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Juvenile psoriatic arthritis 5 2021-03-31
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma Recruiting

2024-516078-31-00 Recurrent and Primary Refractory Ewing Sarcoma 10 2015-05-05
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended

2025-521918-26-00 HIV Infections 4 2026-02-11
An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachmen… Ended

2025-520629-19-00 HIV Infections 3 2025-10-01
Study to evaluate the safety and efficacy of a treatment consisting of immunotherapy by subcutaneous injection of a combination of Der p 1/D… Ended

2024-518519-20-01 moderate/severe allergic rhinitis/rhinoconjunctivitis w 4 2025-04-10
Clinical Trial of Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas Ended

2024-511987-10-00 Selected Advanced Soft-Tissue Sarcomas 4 2025-04-07
Clinical trial to evaluate effectiveness and cost-effectiveness of pre-emptive genotyping strategy to optimise tacrolimus dosage in a pretra… Ended

2024-516596-32-00 Kidney transplant 6 2025-03-31
A Study to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine Ended

2024-512946-41-00 Menstrual Migraine 5 2025-03-05
Phase 3 Study of ALXN1850 versus Placebo in Adolescent and Adult Participants with HPP who have not previously been treated with Asfotase Al… Ended

2023-505673-32-00 Hypophosphatasia 5 2024-08-05